Papers of the Week

Urinary tract stones are common and usually painful. Lifetime prevalence is approximately 10%. Direct healthcare costs are estimated to be over $10 billion dollars annually. First-line treatment is typically analgesia with non-steroid anti-inflammatory drugs until the stone passes. If the stone does not pass spontaneously, urological intervention may be necessary.